Abstract

Comparative proteomic analysis of plasma from bipolar depression and depressive disorder: identification of proteins associated with immune regulatory.

Highlights

  • Immune dysregulation in bipolar II depressionThe complement and coagulation cascade pathways were enriched (P < 0.01) and five proteins were found to be involved in the pathway: C3, CFI, C4BPα,kininogen-1, and antithrombin

  • Bipolar disorder (BD) is a debilitating psychiatric mood disorder affecting approximately 1%–3% of the population worldwide (Merikangas, 2007)

  • A proteomic analysis based on two-dimensional electrophoresis (2-DE) coupled with matrix-assisted laser desorption/ionization-time-of-flight/time-of-flight tandem mass spectrometry (MALDI-TOF/TOF MS) was carried out on plasma samples from drug-naïve bipolar II and major depressive disorder (MDD) patients, In order to overcome the limitations of a narrow linear range and large variations in 2-DE, 15 samples were mixed within each study group, and for each group, 2-DE was repeated in triplicate to limit run-to-run variations to about 20%, the criterion of 2-fold change was used as a cut off to ensure the reliability of apparent differences

Read more

Summary

Immune dysregulation in bipolar II depression

The complement and coagulation cascade pathways were enriched (P < 0.01) and five proteins were found to be involved in the pathway: C3, CFI, C4BPα,kininogen-1, and antithrombin. C3, CFI, and C4BPα were included in the pathway of complement cascades (P < 0.05). The quantitative results trends in expression patters were consistent with the MALDI -TOF/TOF MS findings, the changes were smaller than those determined by 2-DE, the differences were statistically significant, and the expression levels of these three proteins being significantly dysregulated with the following profiles: C3, MDD > bipolar II > HC subjects; CFI and C4BPα, HC > MDD > bipolar II subjects (Fig. 2A–C). The findings reported here provide evidence demonstrating that autoimmune dysregulation is involved in the pathophysiological mechanisms either bipolar II or MDD. C3 was considered as a significant feature of complement pathway activation because of its key role in all

Bipolar II MDD
Findings
OPEN ACCESS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call